|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.901
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.820
|
|
|
|
purinergic nucleotide receptor signaling pathway
|
GO:0035590 |
3 |
0.737
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.726
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.626
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.616
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.558
|
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.531
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.449
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.442
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.437
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.435
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.433
|
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.431
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.425
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.424
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.417
|
|
|
|
g protein coupled purinergic nucleotide receptor signaling pathway
|
GO:0035589 |
1 |
0.407
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.405
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.392
|
|
|
|
metanephric mesenchymal cell migration
|
GO:0035789 |
2 |
0.376
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.371
|
|
|
|
metanephric glomerular epithelial cell differentiation
|
GO:0072312 |
2 |
0.358
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.355
|
|
|
|
cell migration involved in metanephros development
|
GO:0035788 |
2 |
0.338
|
|
|
|
metanephric glomerular visceral epithelial cell differentiation
|
GO:0072248 |
2 |
0.334
|
|
|
|
negative regulation of lipase activity
|
GO:0060192 |
7 |
0.327
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.308
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.304
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.300
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.291
|
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.287
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.287
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.279
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.266
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.265
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.264
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.263
|
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.262
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.258
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.244
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.241
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.238
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.236
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.227
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.223
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.215
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.210
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.209
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.208
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.191
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.184
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.182
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.181
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.179
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.175
|
|
|
|
cell migration involved in kidney development
|
GO:0035787 |
3 |
0.175
|
|
|
|
regulation of epithelial cell differentiation involved in kidney development
|
GO:2000696 |
10 |
0.173
|
|
|
|
renal filtration cell differentiation
|
GO:0061318 |
10 |
0.170
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.169
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.168
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.165
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.162
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.162
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.158
|
|
|
|
regulation of monocyte chemotaxis
|
GO:0090025 |
3 |
0.154
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.154
|
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.154
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.151
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.146
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.144
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.143
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.143
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.141
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.141
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.139
|
|
|
|
macrophage migration inhibitory factor signaling pathway
|
GO:0035691 |
2 |
0.138
|
|
|
|
renal protein absorption
|
GO:0097017 |
1 |
0.137
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.136
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.134
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.134
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.133
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.133
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.132
|
|
|
|
negative regulation of type i hypersensitivity
|
GO:0001811 |
1 |
0.132
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.130
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.126
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.124
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.123
|
|
|
|
positive regulation of muscle adaptation
|
GO:0014744 |
2 |
0.122
|
|
|
|
positive regulation of metanephric glomerulus development
|
GO:0072300 |
4 |
0.122
|
|
|
|
positive regulation of glomerulus development
|
GO:0090193 |
5 |
0.119
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.118
|
|
|
|
regulation of type ii hypersensitivity
|
GO:0002892 |
4 |
0.117
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.115
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.114
|
|
|
|
regulation of renal albumin absorption
|
GO:2000532 |
1 |
0.113
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.112
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
12 |
0.111
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.107
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.107
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.106
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.106
|
|
|
|
response to thyroid hormone
|
GO:0097066 |
2 |
0.105
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.104
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.103
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.101
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.100
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.100
|
|
|
|
b cell receptor signaling pathway
|
GO:0050853 |
20 |
0.098
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.097
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.097
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.096
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.095
|
|
|
|
antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii
|
GO:0002504 |
17 |
0.095
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.095
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.094
|
|
|
|
negative regulation of metanephric mesenchymal cell migration
|
GO:2000590 |
1 |
0.093
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.093
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.093
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.093
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.093
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.087
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.087
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.087
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.087
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.086
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.086
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.086
|
|
|
|
positive regulation of camp dependent protein kinase activity
|
GO:2000481 |
3 |
0.085
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.084
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.084
|
|
|
|
cerebellar granular layer formation
|
GO:0021684 |
9 |
0.083
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.083
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.083
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.083
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.083
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.082
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.082
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.081
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.080
|
|
|
|
glomerular visceral epithelial cell development
|
GO:0072015 |
6 |
0.080
|
|
|
|
positive regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000478 |
1 |
0.080
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.079
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.079
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.078
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.077
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.076
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.075
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.074
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.074
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.074
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.073
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.073
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.073
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.073
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.072
|
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
10 |
0.071
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.071
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.071
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.071
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.070
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.069
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.069
|
|
|
|
glomerular epithelial cell development
|
GO:0072310 |
6 |
0.068
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.068
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.068
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.068
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.068
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.067
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.067
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.067
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.066
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.066
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.066
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.066
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.065
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.065
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.065
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.064
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.064
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.064
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.064
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.063
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.063
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.063
|
|
|
|
response to hydroperoxide
|
GO:0033194 |
6 |
0.063
|
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.063
|
|
|
|
positive regulation of renal albumin absorption
|
GO:2000534 |
1 |
0.063
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.062
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.062
|
|
|
|
cerebellar granule cell differentiation
|
GO:0021707 |
9 |
0.062
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.062
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.062
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.062
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.062
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.060
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.060
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.060
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.059
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ii
|
GO:0019886 |
14 |
0.059
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.059
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.059
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.058
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.058
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.058
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.058
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.058
|
|
|
|
cerebellar granular layer development
|
GO:0021681 |
13 |
0.058
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.057
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.057
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.056
|
|
|
|
cellular response to ammonium ion
|
GO:0071242 |
2 |
0.056
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.055
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.055
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.055
|
|
|
|
positive regulation of type iii hypersensitivity
|
GO:0001805 |
3 |
0.055
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.055
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.055
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.055
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.055
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.055
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.055
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.054
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.054
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.054
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.054
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.054
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.054
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.054
|
|
|
|
negative regulation of kidney development
|
GO:0090185 |
15 |
0.053
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.053
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.053
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.053
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.053
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.052
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.052
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.052
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.052
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.052
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.051
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.051
|
|
|
|
regulation of type iii hypersensitivity
|
GO:0001803 |
3 |
0.051
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.051
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.050
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.050
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.050
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.050
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.049
|
|
|
|
negative regulation of inflammatory response to antigenic stimulus
|
GO:0002862 |
10 |
0.049
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.049
|
|
|
|
antigen processing and presentation of peptide antigen via mhc class ii
|
GO:0002495 |
17 |
0.049
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.049
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.049
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.049
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.049
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.048
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.048
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.048
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.048
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.048
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.048
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.048
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.048
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.048
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0045425 |
2 |
0.047
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.047
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.046
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.046
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.046
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.046
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.045
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.045
|
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.045
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.045
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.045
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.045
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.044
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.044
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.044
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.044
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.043
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.042
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.042
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.042
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.042
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.042
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.042
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.042
|
|
|
|
detection of oxidative stress
|
GO:0070994 |
1 |
0.042
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.042
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.041
|
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.041
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.041
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.041
|
|
|
|
regulation of metanephric glomerular visceral epithelial cell development
|
GO:2000477 |
1 |
0.041
|
|
|
|
complement activation classical pathway
|
GO:0006958 |
2 |
0.041
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.041
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.040
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.040
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.039
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.039
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.039
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.039
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.039
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.038
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.038
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.038
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.038
|
|
|
|
cell cell junction maintenance
|
GO:0045217 |
3 |
0.038
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.038
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.038
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.037
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.037
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.037
|
|
|
|
cd4 positive alpha beta t cell proliferation
|
GO:0035739 |
2 |
0.037
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.037
|
|
|
|
positive regulation of epithelial cell differentiation involved in kidney development
|
GO:2000698 |
2 |
0.037
|
|
|
|
humoral immune response mediated by circulating immunoglobulin
|
GO:0002455 |
14 |
0.037
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.037
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.036
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.036
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.036
|
|
|
|
biological phase
|
GO:0044848 |
20 |
0.036
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.036
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.036
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.036
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.036
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.035
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.035
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.035
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.035
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.035
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.035
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.034
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.034
|
|
|
|
immune response inhibiting cell surface receptor signaling pathway
|
GO:0002767 |
3 |
0.034
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.034
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.034
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.034
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.034
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.034
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.034
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.034
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.033
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.033
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.033
|
|
|
|
cellular response to hydroperoxide
|
GO:0071447 |
4 |
0.033
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.033
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.033
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.033
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.032
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.032
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.032
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.032
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.032
|
|
|
|
positive regulation of natural killer cell chemotaxis
|
GO:2000503 |
1 |
0.032
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.032
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.032
|
|
|
|
negative regulation of metanephros development
|
GO:0072217 |
6 |
0.032
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.032
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.032
|
|
|
|
positive regulation of metanephros development
|
GO:0072216 |
9 |
0.031
|
|
|
|
fc epsilon receptor signaling pathway
|
GO:0038095 |
3 |
0.031
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.031
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.031
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.031
|
|
|
|
cerebellar granular layer morphogenesis
|
GO:0021683 |
10 |
0.031
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.031
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.031
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.031
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.031
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.030
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.030
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.030
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.030
|
|
|
|
positive regulation of glucose import
|
GO:0046326 |
14 |
0.030
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.030
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.030
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.030
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.030
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
15 |
0.030
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.029
|
|
|
|
negative regulation of erk1 and erk2 cascade
|
GO:0070373 |
21 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.029
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.029
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.029
|
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.029
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.029
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.029
|
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.028
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.028
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.028
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.028
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.028
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.028
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.027
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.027
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.027
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.027
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.027
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.027
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.027
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.027
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.027
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.027
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.027
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.027
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.027
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.027
|
|
|
|
hair cycle phase
|
GO:0044851 |
16 |
0.026
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.026
|
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.026
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.026
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.026
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.026
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.026
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.026
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.026
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.026
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.026
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.026
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.025
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.025
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.025
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.025
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.025
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.025
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.025
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.024
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.024
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.024
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.024
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.024
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.024
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.023
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.023
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.023
|
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.023
|
|
|
|
glomerular epithelium development
|
GO:0072010 |
11 |
0.023
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.023
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.023
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.023
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.023
|
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
20 |
0.023
|
|
|
|
negative regulation of mast cell degranulation
|
GO:0043305 |
4 |
0.023
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.022
|
|
|
|
positive regulation of leukocyte degranulation
|
GO:0043302 |
10 |
0.022
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.022
|
|
|
|
negative regulation of adaptive immune response
|
GO:0002820 |
25 |
0.022
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.022
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.022
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.022
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.022
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.022
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.022
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.022
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.022
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.022
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.021
|
|
|
|
granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0042253 |
2 |
0.021
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.021
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.021
|
|
|
|
renal albumin absorption
|
GO:0097018 |
1 |
0.021
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.021
|
|
